Health / Pharamceutical

FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly Dosing Regimens

Published Aug 20 2020 at 5:08 AM GMT

Key
Points

Amgen (NASDAQ:AMGN) today announced the US Food and Drug Administration (FDA) has approved the expansion of the Kyprolis (carfilzomib) US prescribing information to include its use in.